3,3-二氨基聯苯胺四鹽酸鹽74-49-6/硒試劑/3,4,3′,4′-四氨基聯苯四鹽酸鹽/3,3-二氨基聯苯胺鹽酸鹽/(,'-聯苯)-3,3'4,4'-四胺四鹽酸鹽/鹽酸-3,3′-二氨基聯苯胺/DAB試劑級,98%,無水物5克,Sigma-Aldrich、Amresco、Amersham、Serva、AppliChem等品牌,
試劑級,98%,水合物5克,Sigma-Aldrich、Amresco、Amersham、Serva、AppliChem等品牌,
試劑級,98%,二水物5克,Sigma-Aldrich、Amresco、Amersham、Serva、AppliChem等品牌,
25克,Sigma-Aldrich、Amresco、Amersham、Serva、AppliChem等品牌,
3,3-二氨基聯苯胺四鹽酸鹽74-49-6服務承諾:工作時間內提供免費的技術咨詢和指導 。我公司的銷售工程師經過專業培訓的,將為您提供滿意的產品和真誠的服務。
中文名稱:
其他中文名稱: 3,4,3′,4′-四氨基聯苯四鹽酸鹽;硒試劑;3,3-二氨基聯苯胺鹽酸鹽;(,'-聯苯)-3,3'4,4'-四胺四鹽酸鹽;鹽酸-3,3′-二氨基聯苯胺
英文名稱: DAB
其他英文名稱: 3,3′-Diaminobenzidine tetrahydrochloride dihydrate;3,3',4,4'-Biphenyltetramine tetrahydrochloride dihydrate
產品規格: 試劑級,98%,二水物
包裝:0克
產品規格: 試劑級,98%,水合物
包裝:0克
產品規格: 試劑級,98%,無水物
包裝:0克
:67684-7-5
C2H4N4?4HC?2H2O=396.5
級別:Reagent Grade
含量:≥98.0%
水溶解試驗:合格
對硒靈敏度試驗:合格
:868272-85-9
C2H4N4?4HC?xH2O=360.(anhydrous basis)
級別:Reagent Grade
含量:≥98.0%
:74-49-6
C2H4N4?4HC=360.
Solubility (5%, Water):合格
性狀:淡棕色粉末或灰色結晶粉末。中度溶于水,不溶于大多數有機溶劑。熔點300℃
品名稱 | |
英文名稱 | DAB |
規格 | 可接受大包訂制 |
客戶可根據 的性質、化學式、分子式、結構式、比重、密度、、沸點、熔點、水溶性、MSDS、用途、作用、規格包裝、性狀、注意事項、英文名、別稱、純度、級別等情況,本產品化學性質穩定,運輸條件不苛刻,一般儲存在陰涼,干燥,通風良好的地方,遠離不相容的物質。保持容器密閉。
公司提供的 *,貨源充足。嚴格的質量控制體系,包括:優級純,分析純,化學純,試劑級,基準試劑,實驗純,教學試劑,高純試劑,色譜純,光譜純,電子純。各種包裝規格,并可提供包裝定制,咨詢、訂購。
G抗原0(GAGE0)ELISA試劑盒 ,英文名: GAGE0 ELISA Kit
G抗原(GAGE)ELISA試劑盒 ,英文名: GAGE ELISA Kit
G底物(GSBS)ELISA試劑盒 ,英文名: GSBS ELISA Kit
G蛋白偶聯受體家族C5組成員A(GPRC5A)ELISA試劑盒 ,英文名: GPRC5A ELISA Kit
G蛋白偶聯受體78(GPR78)ELISA試劑盒 ,英文名: GPR78 ELISA Kit
G蛋白偶聯受體37(GPR37)ELISA試劑盒 ,英文名: GPR37 ELISA Kit
G蛋白偶聯受體20(GPR20)ELISA試劑盒 ,英文名: GPR20 ELISA Kit
G蛋白偶聯雌激素受體(GPER)ELISA試劑盒 ,英文名: GPER ELISA Kit
G蛋白α抑制活性多肽3(GNαI3)ELISA試劑盒 ,英文名: GNαI3 ELISA Kit
G補綴FHA域血管生成因子(AGGF)ELISA試劑盒 ,英文名: AGGF ELISA Kit
GTP環化水解酶(GCH)ELISA試劑盒 ,英文名: GCH ELISA Kit
Gremlin2蛋白(GREM2)ELISA試劑盒 ,英文名: GREM2 ELISA Kit
Gremlin蛋白(GREM)ELISA試劑盒 ,英文名: GREM ELISA Kit
GPI錨定分子樣蛋白(GML)ELISA試劑盒 ,英文名: GML ELISA Kit
Goosecoid2蛋白(GSC2)ELISA試劑盒 ,英文名: GSC2 ELISA Kit
Goosecoid蛋白(GSC)ELISA試劑盒 ,英文名: GSC ELISA Kit
GM2激活因子(GM2A)ELISA試劑盒 ,英文名: GM2A ELISA KitXAV939 (25 mg) 3,5,7,8-tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one; XAV939
XAV939 (5 mg) 3,5,7,8-tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one; XAV939
IWR--exo (0 mg) 4-[(3aR,4S,7R,7aS)-,3,3a,4,7,7a-hexahydro-,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinyl-benzamide; IWR--exo
IWR--exo (25 mg) 4-[(3aR,4S,7R,7aS)-,3,3a,4,7,7a-hexahydro-,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinyl-benzamide; IWR--exo
IWR--exo (5 mg) 4-[(3aR,4S,7R,7aS)-,3,3a,4,7,7a-hexahydro-,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinyl-benzamide; IWR--exo
IWR--exo (50 mg) 4-[(3aR,4S,7R,7aS)-,3,3a,4,7,7a-hexahydro-,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinyl-benzamide; IWR--exo
ZM 447439 (0 mg) N-[4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl]amino]phenyl]-benzamide; ZM 447439
ZM 447439 (5 mg) N-[4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl]amino]phenyl]-benzamide; ZM 447439
ZM 447439 (50 mg) N-[4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl]amino]phenyl]-benzamide; ZM 447439
S-Adenosylhomocysteine (0 mg) S-(5’-deoxyadenosin-5’-yl)-L-homocysteine; SAH|AdoHcy; S-Adenosylhomocysteine
S-Adenosylhomocysteine (25 mg) S-(5’-deoxyadenosin-5’-yl)-L-homocysteine; SAH|AdoHcy; S-Adenosylhomocysteine
S-Adenosylhomocysteine (5 mg) S-(5’-deoxyadenosin-5’-yl)-L-homocysteine; SAH|AdoHcy; S-Adenosylhomocysteine
S-Adenosylhomocysteine (50 mg) S-(5’-deoxyadenosin-5’-yl)-L-homocysteine; SAH|AdoHcy; S-Adenosylhomocysteine
(phenylmethyl)-ethanimidamide, monohydrobromide; N-Benzylacetamidine (hydrobromide)
3,4-dihydro-5-keto-tetranor Prostaglandin Fα (0 ug) 9α,α-dihydroxy-5-oxo-2,3,4,5-tetranor prostanoic acid; 3,4-dihydro-5-keto-tetranor Prostaglandin Fα
3,4-dihydro-5-keto-tetranor Prostaglandin Fα (00 ug) 9α,α-dihydroxy-5-oxo-2,3,4,5-tetranor prostanoic acid; 3,4-dihydro-5-keto-tetranor Prostaglandin Fα
3,4-dihydro-5-keto-tetranor Prostaglandin Fα (25 ug) 9α,α-dihydroxy-5-oxo-2,3,4,5-tetranor prostanoic acid; 3,4-dihydro-5-keto-tetranor Prostaglandin Fα
3,4-dihydro-5-keto-tetranor Prostaglandin Fα (50 ug) 9α,α-dihydroxy-5-oxo-2,3,4,5-tetranor prostanoic acid; 3,4-dihydro-5-keto-tetranor Prostaglandin Fα
3-bromo-5-phenyl Salicylic Acid ( mg) 5-bromo-4-hydroxy-[,’-biphenyl]-3-carboxylic acid; NSC 096; 3-bromo-5-phenyl Salicylic Acid
3-bromo-5-phenyl Salicylic Acid (0 mg) 5-bromo-4-hydroxy-[,’-biphenyl]-3-carboxylic acid; NSC 096; 3-bromo-5-phenyl Salicylic Acid
3-bromo-5-phenyl Salicylic Acid (25 mg) 5-bromo-4-hydroxy-[,’-biphenyl]-3-carboxylic acid; NSC 096; 3-bromo-5-phenyl Salicylic Acid
3-bromo-5-phenyl Salicylic Acid (5 mg) 5-bromo-4-hydroxy-[,’-biphenyl]-3-carboxylic acid; NSC 096; 3-bromo-5-phenyl Salicylic Acid
YM-20636 ( mg) 6-amino-N-[3-[4-(4-morpholinyl)pyrido[3’,2’:4,5]furo[3,2-d]pyrimidin-2-yl]phenyl]-3-pyridinecarboxamide; YM-20636
YM-20636 (0 mg) 6-amino-N-[3-[4-(4-morpholinyl)pyrido[3’,2’:4,5]furo[3,2-d]pyrimidin-2-yl]phenyl]-3-pyridinecarboxamide; YM-20636
活性大紅 | 活性艷紅 | 酸性艷紅 | 5(6)-羧基熒光素72088-94-9 |
酸性橙2934-20-9 | 釕紅03-72-3 | ,3-茚二酮606-23-5 | N-(4-氨基丁基)-N-乙基異魯米諾6662-29- |
4-氨基-3-肼基-5-巰基-,2,4-三氮唑750-2-5 | 4-芐基氨基-7-硝基苯并氧雜惡二唑8378-20-6 | ||